SC 13G

Company

Aptose Biosciences Inc.

Filed

November 26, 2014

Accession Number

0001144204-14-071153

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →